A study led by Guadalupe Sabio and José Jalife at the Centro Nacional de Investigaciones Cardiovasculares (CNIC) in Madrid has identified a new signaling mechanism implicated in the development of ...
A new study by researchers at the University of Arizona College of Medicine – Phoenix and the University of California Davis Health identified a new target for developing a therapy to treat atrial ...
Mutations in genes that form the desmosome are the most common cause of the cardiac disease arrhythmogenic cardiomyopathy (ACM), which affects one in 2000 to 5000 people worldwide. Researchers have ...
A team at the Centro Nacional de Investigaciones Cardiovasculares (CNIC) has made a breakthrough discovery in the understanding of cardiac arrhythmias by unraveling the complexities of Andersen-Tawil ...
A new study by researchers at the University of Arizona College of Medicine – Phoenix and the University of California Davis Health identified a new target for developing a therapy to treat atrial ...
A new study conducted by researchers at the University of Arizona College of Medicine-Phoenix and the University of California Davis Health found a new target for developing a medication to treat ...
US-based Vektor Medical has secured the CE mark for its non-invasive vMap System, designed to assist physicians in the treatment of individuals with arrhythmias.
MyChesCo on MSN
Windtree Therapeutics Files Patent Application in India for Istaroxime, Advancing Arrhythmia Treatment
WARRINGTON, PA — Windtree Therapeutics, Inc. (NasdaqCM: WINT) has filed a national phase patent application with the Indian ...
Researchers sought to determine the relationship between cannabis use and risk for arrhythmia in patients with and without ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback